MRI in the Diagnosis of MS:Comparison of Clinical Eval, Evoked Potentials, Oligoclonal Banding, & CT
Neurol 38:180-185, 309-3141988., Paty,D.W.,et al, 1988
Mlutiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-Up
Arch Neurol 65:727-732, The Optic Neuritis Study Group, 2008
Open-Ring Imaging Sign
Neurol 54:1427-1433, Masdeu,J.C.,et al, 2000
Paraneoplastic Demyelinating Disorder in the Brain of a Patient with Seminoma
J Comput Assist Tomogr 22:136-138, Wong,K.,et al, 1998
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Marchiafava-Bignami Disease:Use of Contrast Media in CT and MRI
Neuroradiology 36:509-511, Caparros-Lefebvre,D.,et al, 1994
Large Focal Tumor-Like Demyelinating Lesions of the Brain:Intermed Entity Between MS & Acute Dissem Encephalomyelitis?
Ann Neurol 33:18-27, Kepes,J.J., 1993
The Accuracy of Magnetic Resonance Imaging in Patients with Suspected Multiple Sclerosis
JAMA 269:3146-3151, Mushlin,A.I.,et al, 1993
Effect of Brain Irradiation on Demyelinating Lesions
Neurol 43:2105-2112, Peterson,K.,et al, 1993
Multiple Sclerosis:Histopath and MR and/or CT Correlation in 37 Cases at Biopsy and Three Cases at Autopsy
Radiology 180:467-474, Nesbit,G.M.,et al, 1991
Inflammatory Myelinoclastic Diffuse Sclerosis (Schilder's Disease) :Neuroradiological Findings
AJNR 10:176-180, Mehler,M.F.&Rabinowich,L., 1989
Magnetic Resonance Imaging of the Central Nervous System Council on Scientific Affairs
Report of the Panel on MRI, JAMA 259:1211-12221988., , 1988
Multiple Sclerosis Disease Activity Correlates with Gadolinium-Enhanced Magnetic Resonance Imaging
Ann Neurol 21:300-306, Conzalez-Scarano,F.,et al, 1987
Silent Brain Lesions in Patients with Isolated Idiopathic Optic Neuritis
Arch Neurol 43:452-455, Jacobs,L.,et al, 1986
Correlations of Nuclear Magnetic Resonance Imaging, Computerized Tomography, & Clinical Profiles in Multiple Sclerosis
Neurol 36:27-34, Jacobs,L.,et al, 1986
MR Diagnosis of Acute Disseminated Encephalomyelitis
J Comput Assist Tomogr 10:798-801, Atlas,S.W.,et al, 1986
MR Imaging in Adrenoleukomyeloneuropathy
J Comput Assist Tomogr 9:793-796, Bewermeyer,H.,et al, 1985
The Initial Diagnosis of Multiple Sclerosis:Clinical Impact of Magnetic Resonance Imaging
Ann Neurol 17:469-474, Gebarski,S.S.,et al, 1985
Nuclear Magnetic Resonance (NRM) Imaging in White Matter Dis. of the Brain Using Spin-Echo Sequences
J Comput Assist Tomogr 7:290-294, Young,I.R.,et al, 1983
Nuclear Magnetic Resonance Imaging in Multiple Sclerosis
Ann Neurol 13:592-601, Lukes,S.A.,et al, 1983
Nuclear Magnetic Resonance Imaging Of The Brain In Multiple Sclerosis
Lancet 2:1063-1066, Young,I.R.,et al, 1981
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008
Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008
Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007
Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001
European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Isolated Demyelinating Syndromes: Comparison of CSF Oligoclonal Bands and Different MR Imaging Criteria to Predict Conversion to CDMS
Mult Scler 7:359-363, Tintore,M.,et al, 2001
A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993
Gadolinium-Pentetic Acis Magnetic Resonance Imaging in Patients with Relapsing Remitting Multiple Sclerosis
Arch Neurol 49:687-689, Capra,R.,et al, 1992
Serial Gadolinium-Enhanced MR Imaging Scans in Pts with Early Relapsing-Remitting MS:Implic for Clx Trials & Natural Hx
Ann Neurol 29:548-555, Harris,J.O.,et al, 1991
Serial Magnetic Resonance Scanning in Multiple Sclerosis:A Second Prospective Study in Relapsing Patients
Ann Neurol 25:43-49, Willoughby,E.W.,et al, 1989
Magnetic Resonance Imaging in Isolated Noncompressive Spinal Cord Syndromes
Ann Neurol 22:714-723, Miller,D.H.,et al, 1987
New Diagnostic Criteria for Multiple Sclerosis:Guidelines for Research Protocols
Neurol 13:227-231, Poser,C.M.,et al, 1983